Bar-Sela Gil (Gil Bar-Sela, Idan Cohen, Cohen Idan)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 15

Top Topics

Respiratory Syndrome Coronavirus

Clinical Practice

Dendritic Cells

Immune Response

Top Venues

International journal of molecular sciences

International journal of cell biology

Oncology and therapy

Galilee Medical Center

Ben-Gurion University of the Negev (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Galilee Medical Center Jun 01 2015 - Dec 31 2018

Israel

Researcher :: Galilee Medical Center Research Institute and The Azrieli Faculty of Medicine, Bar Ilan University

Ben-Gurion University of the Negev

Israel

Student Ombudsman, Office of the Rector

Achva Academic College

Israel

Instructor and teaching assistant, Microbiology

Ben-Gurion University of the Negev

Israel

Senior teaching assistant, Microbiology :: Department of Life Sciences

Education History

Ben-Gurion University of the Negev

Israel

PHD :: Life Sciences

Ben-Gurion University of the Negev

Israel

MSC :: Life Sciences

Ben-Gurion University of the Negev

Israel

BSC :: life science

Publications

Mathumathi Krishnamohan, Irena Kaplanov, Sapir Maudi-Boker, Muhammad Yousef, Noy Machluf-Katz, Bar-Sela Gil, Moshe Elkabets, Jaison Titus, Marina Bersudsky, Ron N Apte, Elena Voronov, Alex Braiman
Tumor Cell-Associated IL-1α Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment. International journal of molecular sciences 25 (7) (2024)
Mathumathi Krishnamohan, Irena Kaplanov, Sapir Maudi-Boker, Muhammad Yousef, Noy Machluf-Katz, Bar-Sela Gil, Moshe Elkabets, Jaison Titus, Marina Bersudsky, Ron N Apte, Elena Voronov, Alex Braiman
Tumor Cell-Associated IL-1α Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment. International journal of molecular sciences 25 (7) (2024)
Mathumathi Krishnamohan, Irena Kaplanov, Sapir Maudi-Boker, Muhammad Yousef, Noy Machluf-Katz, Bar-Sela Gil, Moshe Elkabets, Jaison Titus, Marina Bersudsky, Ron N Apte, Elena Voronov, Alex Braiman
Tumor Cell-Associated IL-1α Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment. International journal of molecular sciences 25 (7) (2024)
Bar-Sela Gil, Salvatore Campisi-Pfinto, Orit Rozenberg, Raul Colodner, Bar-Sela Gil
The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose. The oncologist (2023)
Bar-Sela Gil, Campisi-Pinto Salvatore, Rozenberg Orit, Abaev Ariel, Khoury Marah, Agbaria Dana, Eitam Harel, Colodner Raul, Khoury Mona, Shalabna Hassan, Samih Yousef, Mahamid Camel, Abu-Amna Mahmoud, Bar-Sela Gil
Evaluation of immune response to anti-COVID-19 booster in cancer patients and chronic medical cannabis users and its association with circulating Eosinophils levels. Cancer communications (London, England) (2022)
Mona Khoury, Bar-Sela Gil, Gil Bar-Sela
"The Two Sides of the Same Coin"-Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained. Pharmaceutics 14 (2) (2022)
Gil Bar-Sela, Bar-Sela Gil, Salvatore Campisi-Pinto, Gil M Lewitus, Lanuel Oz-Ari, Ayellet Jehassi, Avivit Peer, Ilit Turgeman, Olga Vernicova, Paula Berman, Mira Wollner, Mor Moskovitz, David Meiri
Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 2020, 12 , 2447. Cancers 14 (8) (2022)
Salti Talal, Khoury Mona, Awad Karem, Lerenthal Yaniv, Harari-Misgav Reut, Shemesh Ariel, Avraham-Kelbert Moran, Eitam Harel, Salvatore Campisi-Pinto, Abu-Amna Mahmoud, Colodner Raul, Tovbin David, Bar-Sela Gil, Bar-Sela Gil
Neutrophil degranulation and severely impaired extracellular trap formation at the basis of susceptibility to infections of hemodialysis patients. BMC medicine 20 (1) (2022)
Mahmoud Abu-Amna, Talal Salti, Mona Khoury, Bar-Sela Gil, Bar-Sela Gil
Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk? Current treatment options in oncology 22 (2) (2021)
Bar-Sela Gil, Bar-Sela Gil, Adva Avisar, David Loven, Anat Aharon
Circulating blood extracellular vesicles as a tool to assess endothelial injury and chemotherapy toxicity in adjuvant cancer patients. PloS one 15 (10) (2020)
Joshua Aviram, Gil M Lewitus, Yelena Vysotski, Anton Uribayev, Shiri Procaccia, Bar-Sela Gil, Anca Leibovici, Mahmud Abo-Amna, Luiza Akria, Dmitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Or Hazan, Gil Bar-Sela, David Meiri
Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients. Pharmaceuticals (Basel, Switzerland) 13 (12) (2020)
Gil Bar-Sela, Bar-Sela Gil, Salvatore Campisi-Pinto, Gil M Lewitus, Lanuel Oz-Ari, Ayellet Jehassi, Avivit Peer, Ilit Turgeman, Olga Vernicova, Paula Berman, Mira Wollner, Mor Moskovitz, David Meiri
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers 12 (9) (2020)
Adi Litmanovich, Khaled Khazim, Bar-Sela Gil
The Role of Interleukin-1 in the Pathogenesis of Cancer and its Potential as a Therapeutic Target in Clinical Practice. Oncology and therapy 6 (2) (2018)
Khaled Khazim, Etti Ester Azulay, Batya Kristal, Bar-Sela Gil
Interleukin 1 gene polymorphism and susceptibility to disease. Immunological reviews 281 (1) (2018)
Peleg Rider, Yaron Carmi, Bar-Sela Gil
Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations. International journal of cell biology 2016 (2016)